The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: A minimal model analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 79, Issue 4, 1994, Pages 975-983

  O’neal, David N ^a   Kalfas, Anna ^a   Dunning, Patricia L ^a   Christopher, Michael J ^a   Sawyer, Steven D ^a   Ward, Glen M ^a   Alford, Frank P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMAN; INSULIN; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0028148471     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.79.4.7962308     Document Type: Article

References (47)

1. Buchanan CR, Preece MA, Milner RDG. 1991 Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. Br Med J. 302:824-828.
2. Salomon F, Cuneo R, Hesp R, Sonksen P. 1989 The effects of treatment of recombinant growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
3. Degerblad M, Elgindy N, Hall K, Sjoberg H-E, Thoren M. 1992 Potent effect of recombinant growth homrone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387-393.
4. Altszuler N, Rathgeb B, Winkler B, deBodo RC, Steele R. 1968 The effects of growth hormone on carbohydrate and lipid metabolism in the dog. Ann NY Acad Sei. 148:441-458.
5. Frohman LA, Macgillivray MH, Aceto Jr T. 1967 Acute effects of human growth hormone on insulin secretion and glucose utilisation in normal and growth hormone deficient subjects. J Clin Endocrinol Metab. 27:561-567.
6. Bratusch-Marrain PR, Smith D, DeFronzo RA. 1982 The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 55:973-982.
7. Lippe BM, Solomon A, Kaplan MP, Golden S, Hendricks A, Scott M. 1981 Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: responses after acute and chronic human growth hormone administration. J Clin Endocrinol Metab. 53:507-513.
8. Foss MC, Saad MJA, Paccola GM, Paula FJ, Piccinato CE, Moreira AC. 1991 Peripheral glucose metabolism in acromegaly. J Clin Endocrinol Metab. 72:1048-1053.
9. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R. 1986 Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol. 250:E269-E273.
10. Fineberg SE, Merimee TJ. 1974 Acute metabolic effects of human growth hormone. Diabetes. 23:499-504.
11. Bratusch-Marrain P, Smith D, Defronzo R. 1992 The effect of growth hormone on glucose metabolism and insulin secretion in man. Diabetologia. 21:387-393.
12. Nielsen JH, Brundstedt K, Jensen D. 1985 Growth hormone is a potent growth factor for pancreatic beta-cells in vitro. Diabetes. 34(Suppl 1):9A.
13. Swislocki ALM, Hoffman BB, Reaven GM. 1989 Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertension. 2:419-423.
14. Weber K, Martin I, Best JD, Alford FP, Boston RC. 1989 An alternative method for minimal model analysis of intravenous glucose tolerance data. Am J Physiol. 256:E524-E535.
15. Bergman RN, Ziya-Ider Y, Bowden C, Cobelli C. 1979 Quantitative estimation of insulin sensitivity. Am J Physiol. 236:E667-E677.
16. Bergman RN, Phillips L, Cobelli C. 1981 Physiological evaluation of factors controlling glucose tolerance in man. J Clin Invest. 48:1456-1457.
17. Toffolo G, Bergman R, Finegood D, Bowden CR, Cobelli C. 1980 Quantitative estimation of beta-cell sensitivity to glucose in the intact organism. Diabetes. 29:979-990.
18. Jorgensen JOL, Flyvbjerg A, Dinesen J, et al. 1987 Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in a double-blind crossover study. Acta Endocrinol (Copenh). 116:381-386.
19. Schonberg D. 1992 Diagnosis of growth hormone deficiency. Bail-lieres Clin Endocrinol Metab. 6:527-546.
20. Jorgensen JOL, Moller N, Alberti KCCM, Orskov H, Christiansen JS. 1990 Evening versus morning injections of growth hormone (GH) in GH deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab. 70:207-214.
21. Albano JR, Ekins G, Martz G, Turner R. 1972 A sensitive precise radioimmunoassay of serum insulin based on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh). 70:487-509.
22. Alford FP, Bloom S, Nabarro J. 1977 Glucagon levels in normal and diabetic subjects: use of a specific immunosorbent for glucagon radioimmunoassay. Diabetologia. 13:1-6.
23. Heding L. 1975 Radioimmunological determination of c-peptide in serum. Diabetologia. 11:541-548.
24. Itaya K, Ui M. 1965 Colorimetric determination of free fatty adds in biological fluids. J Lipid Res. 6:16-20.
25. Orskov H, Thomsen HG, Yde H. 1968 Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature. 219:193-195.
26. Teale JD, Marks V. 1986 The measurement of insulin-like growth factor-1: clinical applications and significance. Ann Clin Biochem. 23:413-424.
27. Boston RC, Greif PC, Berman M. 1981 Conversational SAAM. An interactive program for kinetic analysis of biological systems. Corn-put Programs Biomed. 13:111-119.
28. Boston R, Weber KM. 1984 Modelling with SAAM and its advancement in assodation with mineral metabolism. Math Biosd. 72:191-198.
29. Berman M. 1963 The formulation and testing of models. Ann NY AcadSd. 108:182-194.
30. Kahn SE, Klaff LJ, Schwartz MW, et al. 1990 Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab. 71:994-1002.
31. Galvin P, Ward G, Walters J, et al. 1992 A simple method for quantification of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabetes Med. 9:921-928.
32. Bengtsson B-A, Brummer R-J, Bosaeus I. 1990 Growth hormone and body composition. Horm Res. 33(Suppl 4):19-24.
33. Brodoff BN, Bleicher SJ (eds). 1982 Diabetes mellitus and obesity. Baltimore: Williams and Wilkins.
34. Sonksen PH, Salomon F, Cuneo R. 1991 Metabolic effects of hypopituitarism and acromegaly. Horm Res. 36(Suppl 1):27-31.
35. McGauley G. 1989 Quality of life asssessment before and after growth hormone treatment in adults with growth hormone defi-dency. Acta Paediatr Scand. 386(Suppl):70-72.
36. Orskov L, Schmitz O, Jorgensen JOL, et al. 1989 Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hypoglycemic clamp techmique. J Clin Endocrinol Metab. 68:276-282.
37. Bergman RN. 1989 Towards physiological understanding of glucose tolerance. Minimal model approach [Lily Lecture]. Diabetes. 38:1512-1527.
38. Nielsen JH. 1982 Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic add synthesis in cultured pancreatic islets. Endocrinology. 100:600-606.
39. Walker J, Chaussain JL, Bougneres PF. 1989 Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal. J Clin Endocrinol Metab. 69:253-258.
40. Takano K, Hizuka N, Asakawa K, et al. 1990 Effects of sc administration of recombinant human insulin-like growth factor-I(IGF-I) on normal human subjects. Endocrinol Jpn. 37:309-317.
41. Ruderman NB, Toews CJ, Shafir E. 1969 Role of free fatty adds in glucose homeostasis. Arch Intern Med. 299-313.
42. Goodman HM. 1967 Effects of growth hormone on glucose utilisation in diaphragm muscle in the absence of increased lipolysis. Endocrinology. 81:1099-1103.
43. Maloff BL, Levine JH, Lockwood DH. 1980 Direct effect of growth hormone on insulin action in rat adipose tissue cultured in vitro. Endocrinology. 107:538-544.
44. Moller N, Butler PC, Antsiferov MA, Alberti KGMM. 1989 Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32:105-110.
45. Blackett PR, Weech PK, McConathy WJ, Fesmire JD. 1982 Growth hormone in the regulation of hyperlipidemia. Metabolism. 31:117-120.
46. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson J, Angelin B. 1992 Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA. 89:6983-6987.
47. Rosen T, Bengstsson B. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 2:285-288